Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% | -13,134,971 (-39.63%) | Filing History |
| 2022-02-14 3:00 pm Purchase | 2021-12-31 | 13G | Rubius Therapeutics, Inc. RUBY | Flagship Ventures Fund IV General Partner LLC | 38,581,526 42.900% | 241,250 (+0.63%) | Filing History |
| 2021-02-16 5:03 pm Purchase | 2020-12-31 | 13G | Rubius Therapeutics, Inc. RUBY | Flagship Ventures Fund IV General Partner LLC | 38,340,276 47.400% | 43,750 (+0.11%) | Filing History |
| 2021-02-16 5:02 pm Sale | 2020-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% | -17,865,181 (-35.02%) | Filing History |
| 2020-02-13 4:15 pm Sale | 2019-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 51,008,692 15.310% | -7,914,311 (-13.43%) | Filing History |